Holen Sie sich die Stockscreener-App
1.96
2.08%
0.04
Handel nachbörslich:
1.99
0.03
+1.53%
Schlusskurs vom Vortag:
$1.92
Offen:
$2
24-Stunden-Volumen:
4.02M
Relative Volume:
2.39
Marktkapitalisierung:
$447.58M
Einnahmen:
$8.95M
Nettoeinkommen (Verlust:
$-21.49M
KGV:
-16.33
EPS:
-0.12
Netto-Cashflow:
$-29.24M
1W Leistung:
+12.00%
1M Leistung:
+15.98%
6M Leistung:
+299.43%
1J Leistung:
+140.25%
1-Tages-Spanne:
$1.915
$2.09
1-Wochen-Bereich:
$1.66
$2.09
52-Wochen-Spanne:
$0.3651
$2.09
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
Firmenname
Lineage Cell Therapeutics Inc
Sektor
Branche
Telefon
510-871-4188
Adresse
2173 Salk Avenue, Suite 200, Carlsbad, CA
Vergleichen Sie LCTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.96 | 438.44M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-20 | Eingeleitet | Craig Hallum | Buy |
| 2022-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-06-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-08-19 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-03-31 | Eingeleitet | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc Aktie (LCTX) Neueste Nachrichten
Lineage Cell Therapeutics advances regenerative medicine with scalable therapies - Traders Union
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings seasonPortfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com
Will Lineage Cell Therapeutics Inc. stock benefit from commodity pricesQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
Will Lineage Cell Therapeutics Inc. stock outperform international peersWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-11-03 06:28:30 - newser.com
Regression analysis insights on Lineage Cell Therapeutics Inc. performanceJuly 2025 Decliners & Weekly Breakout Watchlists - newser.com
How to build a custom watchlist for Lineage Cell Therapeutics Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
How institutional buying supports Lineage Cell Therapeutics Inc. stockPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profile2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
How hedge fund analytics apply to Lineage Cell Therapeutics Inc. stock2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How Lineage Cell Therapeutics Inc. stock reacts to Fed tightening2025 Price Targets & Community Consensus Picks - newser.com
Is Lineage Cell Therapeutics Inc. stock a momentum leaderJuly 2025 Setups & AI Forecast Swing Trade Picks - newser.com
Is Lineage Cell Therapeutics Inc. stock undervalued historicallyMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Tools to monitor Lineage Cell Therapeutics Inc. recovery probabilityNew Guidance & Intraday High Probability Alerts - newser.com
Lineage Cell Therapeutics (LCTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
How Lineage Cell Therapeutics Inc. stock performs during market turbulence2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Lineage Cell Therapeutics Hits New 52-Week High of $1.87 - Markets Mojo
How Lineage Cell Therapeutics Inc. stock moves on employment data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Published on: 2025-11-02 02:45:07 - newser.com
Can Lineage Cell Therapeutics Inc. rally from current levelsJuly 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Published on: 2025-11-02 04:56:29 - newser.com
Lineage Cell Therapeutics to release Q3 2025 results, hosts business update call - Traders Union
Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025 - Business Wire
Finanzdaten der Lineage Cell Therapeutics Inc-Aktie (LCTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):